The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?

Sodium–glucose cotransporter-2 (SGLT-2) inhibitors, also called gliflozins or flozins, are a class of drugs that have been increasingly used in the management of type 2 diabetes mellitus (T2DM) due to their glucose-lowering, cardiovascular (CV), and renal positive effects. However, recent studies su...

Full description

Bibliographic Details
Published in:Journal of Cardiovascular Development and Disease
Main Authors: Michail Koutentakis, Jakub Kuciński, Damian Świeczkowski, Stanisław Surma, Krzysztof J. Filipiak, Aleksandra Gąsecka
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Subjects:
SGLT-2 inhibitors (gliflozins)
T2DM
cardiovascular
ketogenesis
benefits
risks
Online Access:https://www.mdpi.com/2308-3425/10/11/465

Internet

https://www.mdpi.com/2308-3425/10/11/465

Similar Items